Post-PCI acute heart failure is an independent predictor of long-term mortality in patients with chronic kidney disease

Zhaodong Guo,Jin Liu,Guoli Sun,Feier Song,Li Lei,Yibo He,Bowen Liu,Shiqun Chen,Yong Liu,Jiyan Chen
DOI: https://doi.org/10.1016/j.ijcard.2020.05.074
IF: 4.039
2020-12-01
International Journal of Cardiology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>This study aimed to clarify the association of post-percutaneous coronary intervention (PCI) acute heart failure (AHF) with all-cause long-term mortality in patients with chronic kidney disease (CKD).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>In this prospective, observational study, 610 patients with CKD and coronary artery disease (CAD) undergoing PCI were included in the final analysis. Patients were divided to the non post-PCI AHF group (<em>n</em> = 557) and the post-PCI AHF group (<em>n</em> = 53). The diagnosis of post-PCI AHF was based on symptoms, prior cardiovascular history, and potential cardiac and noncardiac precipitants.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The overall incidence of post-PCI AHF was 53/610 (8.7%). The incidence of all-cause long-term mortality was significantly higher in the post-PCI AHF group than in the non post-PCI AHF group (50.9% vs 23.2%, <em>P</em> &lt; .01). The median follow-up period was 7.3 years (interquartile range: 3.7–8.4). After adjusting for left ventricular ejection fraction &lt;40% at discharge, CKD stage, acute myocardial infarction, age and smoking, post-PCI AHF was the strongest predictor of all-cause long-term mortality (hazard ratio: 8.08; 95% CI: 3.04–21.48; <em>P</em> &lt; .01).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>In patients with CKD and CAD undergoing PCI, post-PCI AHF is the strongest predictor of all-cause long-term mortality.</p>
cardiac & cardiovascular systems
What problem does this paper attempt to address?